HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.

13th Edition of International Conference on Neurology and Brain Disorders

October 19-21, 2026

October 19 -21, 2026 | Boston, Massachusetts, USA

INBC 2026

Speaker at Neurology and Brain Disorders - Joe Sam Robinson
Keynote Presentation (In-Person)
Joe Sam Robinson, Mercer University, United States

Since its first literary description by Charles Dickens in 1833, followed by its first scientific description in 1949, interest in sleep disturbances has skyrocketed (over 40,000 documented scientific papers have discussed the problem). Sleep apnea, however, remains an incomplete [....] » Read More

Speaker at Brain Disorders Conference - George Diaz
Keynote Presentation (In-Person)
George Diaz, Memorial Healthcare Systems, United States

Background: Juvenile myoclonic epilepsy (JME) is a common idiopathic generalized epilepsy syndrome that typically manifests during adolescence, with onset most often between the ages of 12 and 18 years. It accounts for approximately 5–10% of all epilepsies and up to 26 [....] » Read More

Speaker at Neurology Conferences - Beth Zanrucha
Oral Presentation (In-Person)
Beth Zanrucha, IntraBio, United States

Objective: To assess the efficacy, safety, and tolerability of levacetylleucine in people with CACNA1A-related disorders. Background: CACNA1A-related disorders refer to a range of rare, progressive, neurological and neurodevelopmental disorders with pathogenic mutations in the c [....] » Read More

Speaker at Neurology Conferences - Beth Zanrucha
Oral Presentation (In-Person)
Beth Zanrucha, IntraBio, United States

Objective: To report efficacy and safety results from the pivotal, Phase 3 trial investigating levacetylleucine in people living with Ataxia-Telangiectasia (A-T). Background: A-T is a rare, autosomal recessive cerebellar ataxia. Levacetylleucine (N-acetyl-L-leucine) is a modifie [....] » Read More

Speaker at Brain Disorders Conference - Laura Steakin
Oral Presentation (In-Person)
Laura Steakin, Rehabilitation Institute at Sinai, United States

Orthostatic hypotension (OH) is frequently encountered during inpatient rehabilitation following ischemic stroke and is associated with dizziness, instability, and therapy disruption during this critical stage of neurorecovery. On our neurorehabilitation unit, OH was identified a [....] » Read More

Speaker at Neurology Conferences - Mackenzie Weber
Oral Presentation (In-Person)
Mackenzie Weber, Rehabilitation Institute at Sinai, United States

Orthostatic hypotension (OH) is frequently encountered during inpatient rehabilitation following ischemic stroke and is associated with dizziness, instability, and therapy disruption during this critical stage of neurorecovery. On our neurorehabilitation unit, OH was identified a [....] » Read More

Speaker at Neuroscience Conference - Giuseppe Varone
Oral Presentation (In-Person)
Giuseppe Varone, McLean Hospital, United States

In Major Depressive Disorder (MDD), intermittent theta-burst stimulation (iTBS) is used to induce LTP-like plasticity that is at least partly dependent on NMDA receptor–mediated synaptic mechanisms, but the temporal dynamics of these effects and their dependence on ongoing [....] » Read More

Speaker at Brain Disorders Conference - Matthew Rathbun
Oral Presentation (In-Person)
Matthew Rathbun, University of Rochester Center for Health + Technology (CHeT), United States

Background: As new therapies are developed across the Alzheimer’s disease (AD) continuum, it is critical that patient and caregiver-reported changes in symptomatic health are incorporated into clinical trials. The US FDA encourages the use of patient and observer-reported o [....] » Read More

Speaker at Neurology Conferences - Toru Kondo
Oral Presentation (In-Person)
Toru Kondo, Hokkaido University, Japan

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of β-amyloid (Aβ) and the formation of neurofibrillary tangles. Although the amyloid cascade hypothesis underscores the centrality of Aβ accumulation, the p [....] » Read More

Speaker at Neuroscience Conference - Beka Solomon
Oral Presentation (In-Person)
Beka Solomon, Tel Aviv University, Israel

The CXCRS/CXL12 axis is a major signal transduction involved in inflammation, cell migration, haematopoiesis and cell homing in the bone marrow. Inhibition of this axis with AMD3100, a reversible antagonist of CXCR4, attenuates the neuroinflammation and mobilizes endogenous hemat [....] » Read More

Speaker at Neurology Conferences - Rafaela Mingione
Oral Presentation (In-Person)
Rafaela Mingione, Universidade Santo Amaro, Brazil

Background: Prionic diseases, such as Transmissible Spongiform Encephalopathies (TSEs) and Creutzfeldt-Jakob disease (CJD), are rare and fatal neurodegenerative disorders caused by the abnormal buildup of misfolded prion protein (PrPsc). Currently there are no efficient therapies [....] » Read More

Speaker at Brain Disorders Conference - Maria Teresa Gil Ogliastri
Oral Presentation (In-Person)
Maria Teresa Gil Ogliastri, Universidad Nacional Artes De Buenos Aires, Argentina

Neurotango is a therapeutic framework that integrates the principles of Dance Movement Therapy (DMT) with the rituals, interpersonal dynamics, and kinetic qualities of Argentine tango, aiming to enhance communication, social interaction, and psychophysical regulation in neurodive [....] » Read More

Speaker at Neurology Conferences - Gao Yang
Oral Presentation (In-Person)
Gao Yang, Yancheng People No1 Hospital, China

Background: Dural arteriovenous fistulas (DAVFs) involving the torcular Herophili are rare intracranial vascular malformations that may produce venous hypertensive encephalopathy (VHE). Because patients frequently present with cognitive decline, gait disturbance, and parkinsonian [....] » Read More

Speaker at Neurology Conferences -  Yatri S Patel
Oral Presentation (In-Person)
Yatri S Patel, SVP Hospital Ahmedabad, India

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the basal ganglia, leading to disabling motor and non-motor symptoms. Long-term dopaminergic therapy, including levodopa and dopami [....] » Read More

Speaker at Neurology Conferences -  Yatri S Patel
Oral Presentation (In-Person)
Yatri S Patel, SVP Hospital Ahmedabad, India

Background: Erenumab, (AMG 334) is a first fully human monoclonal antibody that targets and blocks the canonical Calcitonin Gene related peptide (CGRP) receptor approved for use in migraine. CGRP plays a very pivotal role in patho-physiology of migraine. The objective was to [....] » Read More

Speaker at Neuroscience Conference - Cay Anderson Hanley
Poster Presentation (In-Person)
Cay Anderson Hanley, iPACES, United States

Youth on the autism spectrum (ASD) display varying degrees of deficits in cognitive, motor, and social functioning, areas often targeted with various therapy modalities, most efficiently provided as early interventions. Exercise has long been examined as a potential therapy modal [....] » Read More

Speaker at Neuroscience Conference - Cay Anderson Hanley
Poster Presentation (In-Person)
Cay Anderson Hanley, iPACES, United States

The prevalence of mild cognitive impairment (MCI) in Parkinson’s Disease (PD) has been wide ranging, from 15-90% across reports, likely due to a number of key variables, including age at evaluation, and time since symptom onset (Jellinger, 2024). Additionally, the criteria [....] » Read More

Speaker at Neuroscience Conference - Amelie Guinee
Poster Presentation (In-Person)
Amelie Guinee, Colorado State University, United States

The COVID-19 pandemic introduced widespread disruptions to children’s social, educational, and home environments, often increasing exposure to adversity. Pandemic-related adversity has been broadly associated with differences in children’s general cognitive and mental [....] » Read More

Speaker at Neuroscience Conference - Pavan Patel
Poster Presentation (In-Person)
Pavan Patel, Stephen F. Austin High School, United States

Neurodegenerative diseases affect over 55 million people worldwide, yet accurately distinguishing Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and progressive supranuclear palsy (PSP) remains difficult due to overlapping clinical symptoms and limited disease-spe [....] » Read More

Speaker at Neurology Conferences - Shreyan Shah
Poster Presentation (In-Person)
Shreyan Shah, William P. Clements High School, United States

Neurodegenerative diseases affect over 55 million people worldwide, yet accurately distinguishing Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and progressive supranuclear palsy (PSP) remains difficult due to overlapping clinical symptoms and limited disease-spe [....] » Read More

Speaker at Brain Disorders Conference - Giriish Purushothaman
Poster Presentation (In-Person)
Giriish Purushothaman, Bridgeland High School, United States

This study aims to characterize how specific, clinically unannotated human missense mutations within the ligand-binding Cluster II domain of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) alter its 3D structural conformation and binding affinity for Amyloid-Beta (A&bet [....] » Read More

Speaker at Brain Disorders Conference - Jonathan E Sy
Poster Presentation (In-Person)
Jonathan E Sy, World Citi Medical Center, Philippines

A 19-year-old Filipino male with no significant past medical history presented with a 1-week history of intermittent headache followed by sudden right-sided weakness, vomiting, twitching, tremors, upward eye-rolling, and spasms with transient loss of consciousness and disorientat [....] » Read More

Speaker at Neurology Conferences - Jerico Ryan M Pura
Poster Presentation (In-Person)
Jerico Ryan M Pura, World Citi Medical Center, Philippines

Patient J.Y, a 25 year old male, came in due to a chief complaint of weakness and no verbal output. 2 days prior to consultation, the patient complained of occasional headaches and right-hand numbness however still apparently well at the time. It was elicited from history that th [....] » Read More

Speaker at Neurology Conferences - Daniel Christopher P Maan
Poster Presentation (In-Person)
Daniel Christopher P Maan, World Citi Medical Center, Philippines

Background: Multiple Sclerosis (MS) is a demyelinating disease which is particularly rare in tropical regions like the Philippines, where epidemiologic incidence is 10 to 20 times lower than in temperate zones. Fulminant and tumefactive MS variants, such as the Marburg Variant, p [....] » Read More

Speaker at Neuroscience Conference - Divine Fajardo
Poster Presentation (In-Person)
Divine Fajardo, World Citi Medical Center, Philippines

A 19-year-old Filipino male presented with a one-week history of intermittent headache, followed by focal neurologic symptoms including right-sided lip twitching, right-sided weakness, and vomiting. This progressed to a one-minute episode of generalized tremors, musculoskeletal s [....] » Read More

Speaker at Neuroscience Conference - Jed Hiram Rosales
Poster Presentation (In-Person)
Jed Hiram Rosales, World Citi Medical Center, Philippines

Introduction: Guillain-Barré Syndrome (GBS) is a rare but potentially fatal immune-mediated polyneuropathy typically characterized by symmetrical ascending paralysis. Approximately 20% to 30% of patients experience a rapid "ascending storm" of symptoms leading to [....] » Read More

Speaker at Neuroscience Conference - Jed Hiram Rosales
Poster Presentation (In-Person)
Jed Hiram Rosales, World Citi Medical Center, Philippines

Background: Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) in the pediatric population is characterized by a more aggressive clinical course and higher morbidity compared to adult-onset disease. Diagnostic clarity is often obscured by the mimicry of central nervous system [....] » Read More

Speaker at Brain Disorders Conference - Miguel Quial Ordonez
Poster Presentation (In-Person)
Miguel Quial Ordonez, World Citi Medical Center, Philippines

The patient is R.M., 72-year-old, Filipino male, who came in with a chief complaint of dizziness. Four hours prior to admission, he was walking home when he noted sudden onset non-rotatory dizziness with no associated nausea, vomiting, loss of consciousness, headaches or body wea [....] » Read More

Speaker at Brain Disorders Conference - Kazuhito Toyooka
Keynote Presentation (In-Person)
Kazuhito Toyooka, Drexel University College of Medicine, United States

Activity-dependent neuroprotective protein (ADNP) is essential for cortical development. Heterozygous pathogenic ADNP variants cause Helsmoortel-Van der Aa syndrome (aka ADNP syndrome), a neurodevelopmental disorder that commonly includes intellectual disability, delayed speech a [....] » Read More

Speaker at Neurology Conferences - Yong Xiao Wang
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical College, United States

Vascular dementia (VD) has high morbidity and mortality. Diabetes is a leading factor for VD. The cellular responses and signaling mechanisms for diabetes-induced VD are largely unknown, and the current treatments for VD are neither very specific nor effective. Dysfunctions of ce [....] » Read More

Speaker at Brain Disorders Conference - Daniel Curry
Keynote Presentation (In-Person)
Daniel Curry, Texas Children’s Hospital, United States

Symptomatic hydrocephalus has been treated primarily with cerebrospinal fluid (CSF) diversion since the 1950s. Ventriculoperitoneal and related shunting procedures have been highly effective at relieving acute, life-threatening elevations in intracranial pressure (ICP). However, [....] » Read More

Speaker at Brain Disorders Conference - Daniel Curry
Oral Presentation (In-Person)
Daniel Curry, Texas Children’s Hospital, United States

Gene therapy is reshaping the treatment of pediatric neurological disease, offering durable, non-destructive correction of conditions long considered untreatable. This lecture reviews the spectrum of intracerebral gene therapy strategies—gene addition, modification, deletio [....] » Read More

Speaker at Brain Disorders Conference - Catarina Tristao Pereira
Oral Presentation (In-Person)
Catarina Tristao Pereira, Boston University, United States

Background: Cerebral glucose hypometabolism, measured with 18F-fluorodeoxyglucose (FDG) PET, is a hallmark of Alzheimer’s disease (AD). While FDG-PET changes are highly effective at differentiating dementia types, the pathological bases for metabolic changes are complex. Hy [....] » Read More

Speaker at Neurology Conferences - Ghaith Alsabbagh
Oral Presentation (In-Person)
Ghaith Alsabbagh, University of Illinois Chicago, United States

Survival after cardiac arrest has improved substantially with advances in resuscitation techniques and post–cardiac arrest care. However, hypoxic–ischemic brain injury (HIBI) remains a major cause of mortality and long-term neurological disability among survivors. Con [....] » Read More

Speaker at Brain Disorders Conference - Michelle Wong
Oral Presentation (In-Person)
Michelle Wong, VCOM-Louisiana and Neuromedical Clinic of CenLA, United States

Background: Anti-amyloid monoclonal antibodies, including lecanemab and donanemab, represent an emerging disease-modifying treatment approach for early Alzheimer’s disease. However, treatment is associated with amyloid-related imaging abnormalities (ARIA), including ARIA wi [....] » Read More

Speaker at Brain Disorders Conference - Ons M Saad
Oral Presentation (In-Person)
Ons M Saad, Panluminate Inc., United States

Alzheimer’s neuropathology is commonly described by lesion burden, yet cognitive decline emerges from the disruption of neural circuits. Amyloid-β (Aβ) plaques are associated with local dendritic spine loss, excitatory synapse depletion, impaired axonal transport, [....] » Read More

Speaker at Brain Disorders Conference - Ciro Ramos Estebanez
Oral Presentation (In-Person)
Ciro Ramos Estebanez, University of Illinois Chicago, United States

Survival after cardiac arrest has improved substantially with advances in resuscitation techniques and post–cardiac arrest care. However, hypoxic–ischemic brain injury (HIBI) remains a major cause of mortality and long-term neurological disability among survivors. Con [....] » Read More

Speaker at Neurology Conferences - Anna G Shen
Oral Presentation (In-Person)
Anna G Shen, Newton South High School, United States

Background: Health-related behaviors, including diet, outdoor activity, screen time, and sleep, are important determinants of child health and development, yet little is known about the associations between these behaviors and autism spectrum disorder (ASD) among young children. [....] » Read More

Speaker at Brain Disorders Conference - Vikrant Devgire
Oral Presentation (In-Person)
Vikrant Devgire, Northern Care Alliance, United Kingdom

Background/Aims: Patients requiring a tracheostomy following a neurological insult undergo structured weaning and decannulation through a multidisciplinary approach in hyperacute neurorehabilitation. Despite these efforts, some patients are discharged with a tracheostomy. We [....] » Read More

Speaker at Brain Disorders Conference - Isao Okunishi
Oral Presentation (In-Person)
Isao Okunishi, Kinjirushi Co., Ltd, Japan

Hexaraphane (HXN; 6-methylsulfinylhexyl isothiocyanate) is an isothiocyanate compound derived from the rhizomes and roots of wasabi (Eutrema japonicum). Accumulating evidence demonstrates that HXN exerts potent antioxidant, anti-inflammatory, and neuroprotective activities, suppo [....] » Read More

Speaker at Brain Disorders Conference - Luo Xun
Oral Presentation (In-Person)
Luo Xun, Wenzhou Medical University, China

Background and Objective: Early identification and intervention for childhood developmental disorders, particularly autism spectrum disorder (ASD), depend on a deep understanding of sensory information processing mechanisms. Existing methods still have limitations in terms o [....] » Read More

Speaker at Brain Disorders Conference - Venkata Sai Sulekhya Inturu
Oral Presentation (In-Person)
Venkata Sai Sulekhya Inturu, Mamata Medical College, India

Background: Vertebral artery dissecting aneurysms (VADA) are an uncommon but life-threatening cause of subarachnoid hemorrhage and posterior-circulation stroke. Covered stents are an effective, economical option where flow-diverter availability is limited, but unlike porous flow- [....] » Read More

Speaker at Neuroscience Conference - Sumeet Panjabi
Oral Presentation (In-Person)
Sumeet Panjabi, Genentech, Inc., United States

Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare, autoimmune central nervous system disease causing inflammatory demyelination and neurologic damage. Approximately 50-60% of patients experience a relapsing disease course. A single [....] » Read More

Speaker at Neuroscience Conference - Steven Benvenisti
Keynote Presentation (In-Person)
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States

Traumatic brain injury is the silent epidemic of our time. In spite of over 1.7 million people sustaining a T.B.I. every year in our country, only a very small minority of medical professionals, legal scholars, employers, educators and people understand the reality of what the su [....] » Read More

Speaker at Brain Disorders Conference - Thomas J Webster
Keynote Presentation (In-Person)
Thomas J Webster, Brown University, United States

Nanotechnology has revolutionized numerous industries from space exploration to medicine. This talk will emphasize how nanoparticles can be synthesized by traditional precipitation techniques or by cells to pass through the blood brain barrier to treat brain cancer, brain infecti [....] » Read More

Speaker at Brain Disorders Conference - Li Liu
Keynote Presentation (In-Person)
Li Liu, The First Affiliated Hospital of Xi'an Jiaotong University, China

Objective: This study aims to explore the role and mechanism of Lactobacillus rhamnosus GG (LGG) in alleviating brain damage caused by inflammation in premature mice. Methods: Premature mice were induced by intraperitoneal injection of lipopolysaccharide (LPS). The groups includ [....] » Read More

Speaker at Neuroscience Conference - Ken Ware
Keynote Presentation (Virtual)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and related post-viral conditions such as Long Covid are associated with complex disturbances involving cognition, autonomic regulation, fatigue perception, emotional processing, sensory integration, and motor function. [....] » Read More

Speaker at Neurology Conferences - Robert B Slocum
Keynote Presentation (Virtual)
Robert B Slocum, University of Kentucky HealthCare, United States

Patients with Functional Seizures (FS) (also known as Psychogenic Non-Epileptic Seizures (PNES), have involuntary paroxysmal episodes that resemble epileptic seizures but without organic etiology. Many patients with FS have a history of sexual, physical, or emotional abuse, or ot [....] » Read More

Speaker at Neurology Conferences - Bernd Blobel
Keynote Presentation (Virtual)
Bernd Blobel, University of Regensburg, Germany

For realizing pervasive and ubiquitous health and social care services, health and social care system have to undergo an organizational, methodological and technological transformation towards personalized, participative, preventive, predictive precision medicine. For designing a [....] » Read More

Speaker at Neuroscience Conference - W S El Masri
Keynote Presentation (Virtual)
W S El Masri, Keele University, United Kingdom

Traumatic spinal cord injuries (TSCI) are life-changing events from their medical, physical, psychological, social, financial, vocational, environmental & matrimonial effects. Although the clinical symptoms and signs of the condition was documented in the Edwin Smith papyrus [....] » Read More

Speaker at Brain Disorders Conference - Sergey Victorovich Suchkov
Keynote Presentation (Virtual)
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation, Russian Federation

Over the course of history, healthcare and thus healthcare philosophy have been focused predominantly on efforts to probe the already diseased individual by focusing down on a type of disorder (nosology) rather than on health or so-called pre-illness conditions. Much less effort [....] » Read More

Speaker at Brain Disorders Conference - Zhenhuan Liu
Keynote Presentation (Virtual)
Zhenhuan Liu, Guangzhou University Chinese Medicine, China

Background: Autism spectrum disorders (ASD) are a series of neurodevelopmental disorders characterized by social disorders, rigid behaviors and narrow interests.The World Health Organization (WHO) estimates that the prevalence of ASD has been increasing over the past 50 year [....] » Read More

Speaker at Neurology Conferences - Saul Beaumont
Oral Presentation (In-Person)
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States

Current treatments for dementia remain slow?acting, limited, and often unable to meaningfully change the quality of life for patients and caregivers. Families living with dementia frequently endure a prolonged period of decline that can last many years, marked by progressive cogn [....] » Read More

Speaker at Brain Disorders Conference - Li Liu
Oral Presentation (In-Person)
Li Liu, The First Affiliated Hospital of Xi'an Jiaotong University, China

Background: We aim to investigate the incidence and perinatal risk factors of cranial ultrasound(CUS) abnormalities in hospitalized neonates,build new reference values of cerebral parameters in newborns. Methods: All CUS data of newborns hospitalized in the First Affil [....] » Read More

Speaker at Neuroscience Conference - Alpna Tyagi
Oral Presentation (Virtual)
Alpna Tyagi, University of Colorado-Anschutz Medical Campus, United States

Approximately 6.9 million Americans are living with Alzheimer’s disease (AD), and by 2050, this number is projected to reach nearly 13 million. A significant number of people with AD have coexisting pathologies caused by diseases including, diabetes, hypertension, and cardi [....] » Read More

Speaker at Brain Disorders Conference - Sidharth Patsamatla
Oral Presentation (Virtual)
Sidharth Patsamatla, West Shore Jr/Sr High School, United States

Neuromuscular disorders are a class of conditions that deteriorate the nerves controlling voluntary skeletal muscle, contributing to progressive motor dysfunction, losses in mobility and coordination, and muscle atrophy. According to the National Institutes of Health, it is estim [....] » Read More

Speaker at Brain Disorders Conference - Andrew Shin
Oral Presentation (Virtual)
Andrew Shin, The Harker School - Upper School Campus, United States

Human midbrain organoids are 3-dimension neural tissues derived from iPSC-stem cells. As they self-assemble into layered neural networks, these models capture key aspects of developing human dopaminergic circuitry in a controlled in-vitro setting, enabling mechanistic studies tha [....] » Read More

Speaker at Brain Disorders Conference - Jessica Marchant
Oral Presentation (Virtual)
Jessica Marchant, Texas Woman's University, United States

Over the past two decades, neuroscience research has increasingly demonstrated that the adult brain retains the capacity for reorganization following acquired brain injury (ABI). Despite this growing body of evidence, rehabilitation practice often shifts quickly toward compensato [....] » Read More

Speaker at Brain Disorders Conference - Daniel Zhang
Oral Presentation (Virtual)
Daniel Zhang, Indigo Research, United States

Background: Female glioblastoma (GBM) patients consistently outlive males by 3 to 5 months even after controlling for age, surgical extent, and MGMT methylation status. The biological mechanism driving this survival gap remains unresolved. Nearly all existing research examines gl [....] » Read More

Speaker at Brain Disorders Conference - Meher Garg
Oral Presentation (Virtual)
Meher Garg, Springfield High School, United States

Epilepsy affects over 50 million people worldwide. Approximately one-third of patients are resistant to current treatments with many experiencing adverse side effects. Mutations in the prickle gene, particularly the prickle-spiny-legs (pksple) isoform in Drosophila, produce spont [....] » Read More

Speaker at Brain Disorders Conference - Oren G Nedjar
Oral Presentation (Virtual)
Oren G Nedjar, Nova Southeastern University Kiran C. Patel College of Osteopathic Medicine, United States

Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT) is a rare autoimmune encephalopathy characterized by heterogeneous neuropsychiatric manifestations. We describe the case of a 59-year-old woman with a history of anxiety and severe alcohol use disord [....] » Read More

Speaker at Neuroscience Conference - Dev Sathyan
Oral Presentation (Virtual)
Dev Sathyan, Bridgeland High School, United States

Neuro-Fencing is a therapeutic framework integrating Sport-Based Intervention (SBI) with the technical demands, interpersonal dynamics, and neurocognitive requirements of competitive fencing, designed to enhance executive function, emotional regulation, and social engagement in c [....] » Read More

Speaker at Neurology Conferences - Uttara Koul
Oral Presentation (Virtual)
Uttara Koul, St. Vincent's Medical Center, United States

38-year-old female with Mitochondrial Recessive Ataxia Syndrome (MIRAS, homozygous POLG A467T mutation), diagnosed in her late twenties, was transferred to us from another hospital. She was intubated and sedated for suspected status epilepticus. Her condition had led to progressi [....] » Read More

Speaker at Brain Disorders Conference - Clairisse Whang
Oral Presentation (Virtual)
Clairisse Whang, Robert Wood Johnson University Medical School, United States

Anti-N-methyl-D-aspartate receptor (NMDA-R) encephalitis is a rare but increasingly recognized cause of acute encephalopathy, often masquerading as infectious meningoencephalitis. We present a case of a 45-year-old man with prediabetes, psoriasis, and recent-onset seizures, who [....] » Read More

Speaker at Neuroscience Conference - Elena Ward
Oral Presentation (Virtual)
Elena Ward, University of Liverpool, United Kingdom

Introduction: Central retinal artery occlusion (CRAO) or ocular stroke, has an incidence between 1-10 per 100,000, causing sudden and painless vision loss. Following CRAO there is an increased risk of cerebral stroke, rendering it a potential sight and life-threatening event. Int [....] » Read More

Speaker at Brain Disorders Conference - Carlos Gutierrez Merino
Oral Presentation (Virtual)
Carlos Gutierrez Merino, University of Extremadura, Spain

Kaempferol, a flavonoid present in many food products, has chemical and cellular antioxidant properties that are beneficial for protection against the oxidative stress caused by reactive oxygen and nitrogen species. Kaempferol administration to model experimental animals provides [....] » Read More

Speaker at Neuroscience Conference - Linna Sato
Oral Presentation (Virtual)
Linna Sato, National Institutes for Quantum Science and Technology (QST), Japan

Background: The neurological and psychiatric sequelae of Traumatic Brain Injury (TBI) have become an increasing concern. However, the long-term effects of TBI on brain glucose metabolism, particularly in individuals more than a decade after injury, remain poorly understood. This [....] » Read More

Speaker at Neurology Conferences - Wesam Asaad
Oral Presentation (Virtual)
Wesam Asaad, Independent Researcher, Switzerland

A central question in neuroscience is how complex, structured brain architectures emerge from local cellular interactions during development. Here, we demonstrate that local developmental optimization alone is sufficient to generate realistic brain organization and stable neurodi [....] » Read More

Speaker at Neuroscience Conference - Ki Ji Lee
Oral Presentation (Virtual)
Ki Ji Lee, National Research Foundation, Korea, Republic of

The facial nerve is one of the most commonly damaged cranial nerves. Loss of facial expression and deformation of facial paralysis have serious implications for the physical and psychological well-being of patients. Peripheral facial nerve paralysis is often treated as an aesthet [....] » Read More

Speaker at Brain Disorders Conference - Sergey Victorovich Suchkov
Oral Presentation (Virtual)
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation, Russian Federation

Biomarkers enable pre-early diagnosis, guide targeted therapy and monitor the active ty and therapeutic responses across the diseases. Among the best-validated predictive biomarkers are autoimmunity-related ones to predict and prognosticate risks of the chronification, complicati [....] » Read More

Speaker at Neurology Conferences - Tatiana Korolenko
Oral Presentation (Virtual)
Tatiana Korolenko, Scientific Research Institute of Neurosciences and Medicine, Russian Federation

Dysregulation of autophagy have been shown in several diseases, like atherosclerosis (Yaribejgy et al., 2023), inborn lysosomal storage diseases (Francelle and Mazzulla, 2022) and diabetes Type 2 (Korolenko et al., 2021), concentrating attention at lysosomes as a potential target [....] » Read More

Speaker at Brain Disorders Conference - Sinan Eliacik
Oral Presentation (Virtual)
Sinan Eliacik, Hitit University School of Medicine, Turkey

Epilepsy is increasingly recognized as a disorder of large-scale brain network dysfunction rather than a purely focal pathology. Advances in Network Neuroscience have revealed reproducible alterations in functional connectivity, graph topology, and network dynamics across epilept [....] » Read More

Speaker at Neurology Conferences - Anuradha Sharma
Oral Presentation (Virtual)
Anuradha Sharma, PCTE Group of Institute, India

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which soluble β?amyloid (Aβ) oligomers are key upstream drivers of synaptic dysfunction and cognitive decline. ALZ?801 (valiltramiprosate) is an oral valine?Conjugated prodrug of tra [....] » Read More

Speaker at Neurology Conferences - Rahul Hajare
Oral Presentation (Virtual)
Rahul Hajare, Sandip University, India

The gut brain axis represents a complex, bidirectional communication network integrating the enteric nervous system and the central nervous system through neural, endocrine, immune, and metabolic pathways. Beyond its anatomical connections, this dynamic system operates via the au [....] » Read More

Speaker at Neurology Conferences - Er Kritika
Oral Presentation (Virtual)
Er Kritika, Independent Researcher, India

The current neuroscience studies have produced more than ever before, in terms of quantity of brain data, due to the avenues of neuroimaging used such as fMRI, EEG, MEG, and the new brain-computer interfaces. The traditional informed consent models that were developed many decade [....] » Read More

Speaker at Neurology Conferences - Amgad Elwy
Oral Presentation (Virtual)
Amgad Elwy, Cairo university, Egypt

Background: Spasticity is a major motor impairment in children with cerebral palsy (CP), limiting functional mobility and joint range of motion. Transcutaneous electrical nerve stimulation (TENS) has been suggested as a non-invasive modality to modulate muscle tone through s [....] » Read More

Speaker at Neuroscience Conference - Shalini Dandamudi
Oral Presentation (Virtual)
Shalini Dandamudi, Stockdale High School, United States

Background: Normal Pressure Hydrocephalus (NPH) is a neurological condition characterized by the enlargement of the lateral ventricles in the brain despite normal cerebrospinal fluid pressure. Although this condition is treatable, it is often underdiagnosed due to its similarity [....] » Read More

Speaker at Brain Disorders Conference - Dhruv Bearelly
Poster Presentation (Virtual)
Dhruv Bearelly, University of Cincinnati, United States

Multiple Sclerosis (MS) is an autoimmune disease that affects children and adults nationwide. The goal of this research is to improve the quality of life for patients living with the sometimes debilitating symptoms of MS, specifically through the use of the mRNA-1195 vaccine (als [....] » Read More

Speaker at Neurology Conferences - Shrey Somani
Poster Presentation (Virtual)
Shrey Somani, Dougherty Valley High School, United States

Focal Cortical Dysplasia (FCD) causes epilepsy in 4 million newborns yearly. Treatments are surgical removal of malformed brain tissue, which fails for 40% of patients and causes permanent cognitive defects. FCD arises when neural progenitor cells (NPCs) commit to regional brain [....] » Read More

Speaker at Neuroscience Conference - Jaiden Makadia
Poster Presentation (Virtual)
Jaiden Makadia, Eigen Sciences, United States

Autism spectrum disorder (ASD) lacks fast and reliable blood and molecular detection methods, making early diagnosis difficult. The purpose of this project was to design avimer molecules to bind to the au sm-associated protein CNTF using structure-guided computational modeling. T [....] » Read More

Speaker at Neurology Conferences - Lin Yang
Poster Presentation (Virtual)
Lin Yang, University of Michigan Medical School, United States

Background: Frequent or disproportionately elevated psychological distress can be a sign of mood disorders, such as Major Depressive Disorder and anxiety disorders. Due to its availability and non-invasive nature, salivary cortisol content is often used as an indicator of psychol [....] » Read More

Speaker at Neurology Conferences - Sammi Chou
Poster Presentation (Virtual)
Sammi Chou, Baylor University, United States

Selective serotonin reuptake inhibitors (SSRIs) are first-line treatments but have delayed onset and may initially worsen symptoms; benzodiazepines are sometimes co-prescribed to provide immediate relief. Despite this, research on co-prescription is fragmented across study types [....] » Read More

Speaker at Brain Disorders Conference - Gregory Williams
Poster Presentation (Virtual)
Gregory Williams, Del Sol Medical Center, United States

Hand Foot and Mouth Disease is a common and highly contagious febrile infection mostly secondary to Coxsackievirus A16. The virus can spread to adults and one of the major complications is viral meningitis. This case describes a case of an adult patient who developed viral mening [....] » Read More

Speaker at Neuroscience Conference - Shriya Singh
Poster Presentation (Virtual)
Shriya Singh, Children's National Hospital, United States

Pontocerebellar hypoplasia is a rare neurodevelopmental disorder that results from differences in formation and function of the pons, cerebellum and cerebrum. It can be diagnosed prenatally or postnatally with a combination of clinical, neuroimaging and genetic data obtained over [....] » Read More

Speaker at Neurology Conferences - Angela Philips
Poster Presentation (Virtual)
Angela Philips, University of Illinois College of Medicine Peoria, United States

Objective: We present a rare case of alexia without agraphia in the setting of cerebral venous thrombosis and review the neuroanatomical basis, diagnostic considerations, and clinical relevance of this uncommon presentation. Background: Alexia without agraphia is a rar [....] » Read More

Speaker at Neurology Conferences - Angela Philips
Poster Presentation (Virtual)
Angela Philips, University of Illinois College of Medicine Peoria, United States

Background: Burst suppression is an EEG pattern commonly targeted during treatment of refractory status epilepticus with anesthetic agents, characterized by brief bursts of cerebral activity interspersed with 10-second periods of suppression. In true pharmacologic burst supp [....] » Read More

Speaker at Neuroscience Conference - Lauren Provinsal
Poster Presentation (Virtual)
Lauren Provinsal, Edward Via College of Osteopathic Medicine, United States

Objective: We aim to assess if ChatGPT can be a reliable resource for individuals with neurologic disorders, who may have limited access to registered dietitians, to seek to for a therapeutic nutrition plan. Background: Medical nutrition therapy (MNT) can be a key component for [....] » Read More

Speaker at Brain Disorders Conference - Kiran Ghotra
Poster Presentation (Virtual)
Kiran Ghotra, Lake Erie College of Osteopathic Medicine, United States

Background: Polycystic ovarian syndrome (PCOS) is a complex endocrine disorder typically characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Prenatal exposure to elevated androgen levels, particularly testosterone, has been linked to changes in brain [....] » Read More

Speaker at Brain Disorders Conference - Ruslana Gurskaia
Poster Presentation (Virtual)
Ruslana Gurskaia, Independent Neurological Clinic, Ukraine

Background: Huntington's disease (HD) is a fatal autosomal-dominant neurodegenerative disorder with no approved disease-modifying therapy. Ankylosing spondylitis (AS) is a chronic systemic spondyloarthropathy causing progressive functional disability. Their co-occurrence [....] » Read More

Speaker at Neurology Conferences - Farley Soares Cantidio
Poster Presentation (Virtual)
Farley Soares Cantidio, Hospital Mater Dei, Brazil

Purpose/Objective(s): Glioblastoma (GBM) remains associated with poor prognosis despite multimodality treatment. Real-world cohorts may provide complementary evidence regarding outcomes outside highly selected clinical trial populations. We evaluated clinical characteristics, tre [....] » Read More

Speaker at Neurology Conferences - Sara Forastieri Vicente
Poster Presentation (Virtual)
Sara Forastieri Vicente, University of Puerto Rico School of Medicine, Puerto Rico

Background: Niemann-Pick Disease type C (NPC) is a genetic, lysosomal storage disorder characterized by an inability to transport cholesterol and lipids inside cells. This causes a patient-unique set of visceral and neurological symptoms that can include hepatosplenomegaly, demen [....] » Read More

Speaker at Neurology Conferences - Arun Antony
Poster Presentation (Virtual)
Arun Antony, Jersey Shore, United States

Objective: To analyze the characteristics of patients with dementia admitted as inpatients in the U.S. in 2022. Intro/Background: According to the World Health Organization, 57 million people around the world live with dementia. The symptoms of dementia include impaired short-te [....] » Read More

Speaker at Neurology Conferences - Ava Jacob
Poster Presentation (Virtual)
Ava Jacob, Jersey Shore University Medical Center, United States

Introduction: Scientists continue to explore novel therapies for epilepsy since the current treatment options like medications, epilepsy surgery, neuromodulation and ketogenic diet do not always offer complete seizure control and are associated with side effects. Auditory st [....] » Read More

Whatsapp